Counterfeit Medicines - Report Urges No Compromise And No Concession Of Principle In Maintaining Patient Safety EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the release of the Europe Economics report on 'Safe
Medicines Through Parallel Trade'i.
Source: www.medicalnewstoday.comQLT Announces The Initiation Of A Phase I Trial Of Its Synthetic Retinoid Product QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced that it has initiated a Phase I safety study in
healthy adults of QLT091001, an orally administered synthetic retinoid replacement therapy for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
Source: www.medicalnewstoday.comMillions With Mental Disorders In The Developing World Are Deprived Of Necessary Treatment And Care More than 75% of people suffering from mental disorders in the developing world receive no treatment or care. A new WHO programme launched today, on World Mental
Health Day 2008 highlights the huge treatment gap for a number of mental, neurological and substance use disorders. Across Africa for example, nine out of ten people suffering from epilepsy go untreated, unable to access simple and inexpensive anticonvulsant
drugs which cost less than US$5 a year per person.
Source: www.medicalnewstoday.comBayer Reports Progress In Clinical Program For Riociguat Based on positive Phase II trial findings, Bayer Schering Pharma will move into Phase III trials with its oral agent riociguat (BAY 63-2521). Riociguat is the first member of a new class of vasodilating agents called soluble guanylate cyclase (sGC) stimulators. It is being investigated as a new approach for the treatment of different forms of pulmonary hypertension.
Source: www.medicalnewstoday.comWHO Report Shows Mental Health Services In England Leading The Way In Europe Health Secretary Alan Johnson today welcomed publication of a landmark international report, which highlights that mental
health services in England are leading the way in Europe. The report from the World
Health Organisation, published to mark World Mental
Health Day on 10 October, showed that: - England directs 13.
Source: www.medicalnewstoday.comChina Recalls Ginseng Injections After 3 Deaths A chinese pharmaceutical firm recalled batches of ginseng herbal injections after three people given the treatments died, said a local authority announcement on Thursday in Kunming in southwestern Yunnan Province of China. According to China state news agency Xinhua, the Yunnan Provincial
Health Department said the two recalled batches of "ciwujia" (a type of Siberian ginseng) injections have been tested and no toxins were found.
Source: www.medicalnewstoday.comWatson Receives US FDA Approval For RAPAFLO(TM) (silodosin) For The Treatment Of Benign Prostatic Hyperplasia (BPH) Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved RAPAFLO(TM) (silodosin), the company's new alpha blocker for the treatment of the signs and symptoms of BPH. BPH is the number one reason patients visit urologists and is characterized by urination problems, including decreased urine flow, more frequent urination and nocturia.
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 AM
